Morusin Alleviates Aortic Valve Calcification by Inhibiting Valve Interstitial Cell Senescence Through Ccnd1/Trim25/Nrf2 Axis
Advanced Science · 2024-05 · 11 (20)
DOI: 10.1002/advs.202307319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 19.03.2024. Verfasst von Zongtao Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Calcinosis, Cellular Senescence, Signal Transduction. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Key Technologies Research and Development Program.
Abstract (Originalsprache)
The senescence of aortic valve interstitial cells (VICs) plays a critical role in the progression of calcific aortic valve disease (CAVD). However, the precise mechanisms underlying the senescence of VICs remain unclear, demanding the identification of a novel target to mitigate this process. Previous studies have highlighted the anti‐aging potential of morusin. Thus, this study aimed to explore the therapeutic potential of morusin in CAVD. Cellular experiments reveal that morusin effectively suppresses cellular senescence and cause a shift toward osteogenic differentiation of VICs in vitro. Mechanistically, morusin activate the Nrf2‐mediated antiaging signaling pathway by downregulating CCND1 expression and aiding Keap1 degradation through Trim 25. This activation lead to the upregulated expression of antioxidant genes, thus reducing reactive oxygen species production and thereby preventing VIC osteogenic differentiation. In vivo experiments in ApoE −/− mice on a high‐fat Western diet demonstrate the positive effect of morusin in mitigating aortic valve calcification. These findings emphasize the antiaging properties of morusin and its potential as a therapeutic agent for CAVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
- Hubei Provincial Engineering Technology Research Center for Chinese Medicine Processing, School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, China.
- Hubei Shizhen Laboratory, Wuhan, 430065, China.
- Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, 430022, China.
ORCID-Profile: Kang Xu
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Key Technologies Research and Development Program
Zitieren
APA
Liu, Z., Wang, K., Jiang, C., Chen, Y., Liu, F., Xie, M., Yim, W. Y., Yao, D., Qian, X., Chen, S., Shi, J., Xu, K., Wang, Y., & Dong, N. (2024). Morusin Alleviates Aortic Valve Calcification by Inhibiting Valve Interstitial Cell Senescence Through Ccnd1/Trim25/Nrf2 Axis. Advanced Science, 11(20). https://doi.org/10.1002/advs.202307319
Vancouver
Liu Z, Wang K, Jiang C, Chen Y, Liu F, Xie M, et al. Morusin Alleviates Aortic Valve Calcification by Inhibiting Valve Interstitial Cell Senescence Through Ccnd1/Trim25/Nrf2 Axis. Advanced Science. 2024;11(20). doi:10.1002/advs.202307319
BibTeX
@article{Liu2024,
author = {Liu, Zongtao and Wang, Kan and Jiang, Chen and Chen, Yuqi and Liu, Fayuan and Xie, Minghui and Yim, Wai Yen and Yao, Dingyi and Qian, Xingyu and Chen, Shiqi and Shi, Jiawei and Xu, Kang and Wang, Yixuan and Dong, Nianguo},
title = {Morusin Alleviates Aortic Valve Calcification by Inhibiting Valve Interstitial Cell Senescence Through Ccnd1/Trim25/Nrf2 Axis},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {20},
doi = {10.1002/advs.202307319}
}
EUVIMED